5 news items
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
ACIU
TAK
13 May 24
to tackling some of society's most debilitating illnesses, including Alzheimer's disease. We are excited to partner with AC Immune on this ground-breaking
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
ACIU
TAK
13 May 24
as well as worldwide commercialization.
"At Takeda, we are committed to tackling some of society's most
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
TAK
26 Apr 24
.
American Cancer Society. Cancer Facts & Figures 2024. Atlanta, American Cancer Society; 2024
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
TAK
22 Apr 24
to accelerate open innovation in early-stage drug discovery, and toward the creation of start-up companies for the benefit of society
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
TAK
27 Mar 24
Society, confirms her full support for this pioneering initiative. She stressed that highlighting the challenges of this disease goes beyond the issue
- Prev
- 1
- Next